Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13463955 | 0.91 | CYP1A2 (0.33) | CYP1A2HTTLMNAMAPK1PKM | |
| SCHEMBL18973396 | 0.89 | TLR4 (0.31) | — | |
| SCHEMBL16071827 | 0.88 | — | — | |
| SCHEMBL16071711 | 0.88 | — | — | |
| SCHEMBL16072371 | 0.88 | — | — | |
| SCHEMBL13463953 | 0.87 | CYP1A2 (0.37) | CYP1A2HTTLMNAMAPK1PKM | |
| SCHEMBL13463941 | 0.86 | CYP1A2 (0.38) | CYP1A2HTTLMNAMAPK1 | |
| SCHEMBL13463947 | 0.86 | CYP1A2 (0.38) | CYP1A2HTTLMNAMAPK1 | |
| SCHEMBL13464034 | 0.86 | CYP1A2 (0.40) | CYP1A2HTTLMNAMAPK1PKM | |
| SCHEMBL9613652 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8858829-B2 | Cyclohexane compound and liquid crystal composition containing the same | ORGANO SCIENCE CO., LTD. (JP) | 2014-10-14 | — | — | US | disclosed |
| US-20130092875-A1 | CYCLOHEXANE COMPOUND AND LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME | CHIRACOL CO., LTD. (JP) | 2013-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130092875-A1 | CYCLOHEXANE COMPOUND AND LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME | CNOT1, SCO2, CNOT9 | CYP1A2 449/4885HTT 4318/4885LMNA 1926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.